Dual Peptide-Modified Nanoparticles Improve Combination Chemotherapy of Etoposide and siPIK3CA Against Drug-Resistant Small Cell Lung Carcinoma
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dual Peptide-Modified Nanoparticles Improve Combination Chemotherapy of Etoposide and siPIK3CA Against Drug-Resistant Small Cell Lung Carcinoma
Authors
Keywords
-
Journal
Pharmaceutics
Volume 12, Issue 3, Pages 254
Publisher
MDPI AG
Online
2020-03-13
DOI
10.3390/pharmaceutics12030254
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Combination therapy with the CDK7 inhibitor and the tyrosine kinase inhibitor exerts synergistic anticancer effects against MYCN ‐amplified neuroblastoma
- (2020) Andrew E. Tee et al. INTERNATIONAL JOURNAL OF CANCER
- Lipid nanoparticle-mediated siRNA delivery for safe targeting of human CML in vivo
- (2019) Nidhi Jyotsana et al. ANNALS OF HEMATOLOGY
- Optimization of chitosan nanoparticles as an anti-HIV siRNA delivery vehicle
- (2019) Vahid Iranpur Mobarakeh et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Ratiometric co-encapsulation and co-delivery of doxorubicin and paclitaxel by tumor-targeted lipodisks for combination therapy of breast cancer
- (2019) Chunlai Feng et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- A multi-targeting natural compound with growth inhibitory and anti-angiogenic properties re-sensitizes chemotherapy resistant cancer
- (2019) Wesley F. Taylor et al. PLoS One
- Targeting peptide-decorated biomimetic lipoproteins improve deep penetration and cancer cells accessibility in solid tumor
- (2019) Tao Tan et al. Acta Pharmaceutica Sinica B
- Synergistic effect of the combination therapy on ovarian cancer cells under microfluidic conditions
- (2019) Magdalena Flont et al. ANALYTICA CHIMICA ACTA
- Binding and Internalization in Receptor‐Targeted Carriers: The Complex Role of CD44 in the Uptake of Hyaluronic Acid‐Based Nanoparticles (siRNA Delivery)
- (2019) Julio M. Rios de la Rosa et al. Advanced Healthcare Materials
- Application of Nanoparticles for Targeting G Protein-Coupled Receptors
- (2018) Xin Ma et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Applications of magnetoliposomes with encapsulated doxorubicin for integrated chemotherapy and hyperthermia of rat C6 glioma
- (2018) Natália Babincová et al. ZEITSCHRIFT FUR NATURFORSCHUNG SECTION C-A JOURNAL OF BIOSCIENCES
- β-cyclodextrin based dual-responsive multifunctional nanotheranostics for cancer cell targeting and dual drug delivery
- (2018) Manita Das et al. CARBOHYDRATE POLYMERS
- N-tert-Prenylation of the indole ring improves the cytotoxicity of a short antagonist G analogue against small cell lung cancer
- (2017) Shaun C. Offerman et al. MedChemComm
- Therapeutic applications of the cell-penetrating HIV-1 Tat peptide
- (2015) Mafalda Rizzuti et al. DRUG DISCOVERY TODAY
- Dual-Ligand Modified Polymer-Lipid Hybrid Nanoparticles for Docetaxel Targeting Delivery to Her2/neu Overexpressed Human Breast Cancer Cells
- (2015) Zhe Yang et al. Journal of Biomedical Nanotechnology
- Peptide-conjugated micelles as a targeting nanocarrier for gene delivery
- (2015) Wen Jen Lin et al. JOURNAL OF NANOPARTICLE RESEARCH
- Cell-Penetrating Peptides: Design, Synthesis, and Applications
- (2014) Dana Maria Copolovici et al. ACS Nano
- CD133+ Cancer Stem-like Cells in Small Cell Lung Cancer Are Highly Tumorigenic and Chemoresistant but Sensitive to a Novel Neuropeptide Antagonist
- (2014) S. Sarvi et al. CANCER RESEARCH
- Cytotoxic enhancement of hexapeptide-conjugated micelles in EGFR high-expressed cancer cells
- (2014) Wen Jen Lin et al. Expert Opinion on Drug Delivery
- Marked effects of combined TPGS and PVA emulsifiers in the fabrication of etoposide-loaded PLGA-PEG nanoparticles: In vitro and in vivo evaluation
- (2014) Roonak Saadati et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Calcium phosphate increases the encapsulation efficiency of hydrophilic drugs (proteins, nucleic acids) into poly(d,l-lactide-co-glycolide acid) nanoparticles for intracellular delivery
- (2014) Gregor Dördelmann et al. Journal of Materials Chemistry B
- Targeting Small Cell Lung Cancer Harboring PIK3CA Mutation with a Selective Oral PI3K Inhibitor PF-4989216
- (2013) Marlena Walls et al. CLINICAL CANCER RESEARCH
- Targeting the Phosphoinositide 3-Kinase p110- Isoform Impairs Cell Proliferation, Survival, and Tumor Growth in Small Cell Lung Cancer
- (2012) A. Wojtalla et al. CLINICAL CANCER RESEARCH
- Beyond the imaging: Limitations of cellular uptake study in the evaluation of nanoparticles
- (2012) Emily Gullotti et al. JOURNAL OF CONTROLLED RELEASE
- Small cell lung cancer: new clinical recommendations and current status of biomarker assessment
- (2011) David Planchard et al. EUROPEAN JOURNAL OF CANCER
- Systemic delivery of siRNA with cationic lipid assisted PEG-PLA nanoparticles for cancer therapy
- (2011) Xian-Zhu Yang et al. JOURNAL OF CONTROLLED RELEASE
- Small-cell lung cancer
- (2011) Jan P van Meerbeeck et al. LANCET
- Advances in neuroendocrine lung tumors
- (2010) W. D. Travis ANNALS OF ONCOLOGY
- Cell-penetrating peptide exploited syndecans
- (2010) Tamás Letoha et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
- (2010) T.-C. Chou CANCER RESEARCH
- Recent advances in the use of cell-penetrating peptides for medical and biological applications☆
- (2009) Sonali B. Fonseca et al. ADVANCED DRUG DELIVERY REVIEWS
- Nanomaterial standards for efficacy and toxicity assessment
- (2009) Pavan P. Adiseshaiah et al. Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
- Drug-Selected Human Lung Cancer Stem Cells: Cytokine Network, Tumorigenic and Metastatic Properties
- (2008) Vera Levina et al. PLoS One
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started